TRxADE HEALTH Q4 2022 Earnings Report

TRxADE HEALTH EPS Results

• Actual EPS: -$1.50
• Consensus EPS: -$0.90
• Beat/Miss: Missed by -$0.60
• One Year Ago EPS: N/A

TRxADE HEALTH Revenue Results

• Actual Revenue: $2.53 million
• Expected Revenue: $2.33 million
• Beat/Miss: Beat by +$200.00 thousand
• YoY Revenue Growth: N/A

TRxADE HEALTH Announcement Details

• Quarter: Q4 2022
• Date: 3/27/2023
• Time: N/A

TRxADE HEALTH (NASDAQ:MEDS) operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.